Exponent Sees Q3 FY26 Revenue Before Reimbursements Growth Of 8%-10%; Raises FY26 Revenue Before Reimbursements Growth View To 9%-10%

Benzinga Newsdesk www.benzinga.com Positive 95.6%

Neg 0% Neu 0% Pos 95.6%

Exponent (NASDAQ:EXPO) expects third-quarter fiscal 2026 revenues before reimbursements to increase 8% to 10% year over year. The company also raised its full-year fiscal 2026 outlook and now expects revenues before reimbursements to grow 9% to 10% from fiscal 2025.